PMV Pharmaceuticals (PMVP) Research & Development (2019 - 2026)
PMV Pharmaceuticals' Research & Development came in at $14.68 million for Q2 2026, down 20.2% from $18.4 million a year earlier and down 4.3% from the prior quarter.
Powered by 
Analysis
PMV Pharmaceuticals (PMVP) Research & Development (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, PMV Pharmaceuticals reported Research & Development of $64.04 million, down 3.8% year-over-year; for FY2025, it came in at $69.88 million, up 19.4% from FY2024.
- Research & Development has increased in each of the last seven years, with a five-year compound annual growth rate of 23.9% (FY2020 to FY2025).
- Going back by year, Research & Development was $58.53 million in FY2024 (+4.7%), $55.89 million in FY2023 (+7.5%), $51.99 million in FY2022 (+42.5%) and $36.49 million in FY2021 (+52.5%).
- The Q2 2026 figure represents the lowest quarterly Research & Development since Q4 2024.
- Year-over-year, Research & Development increased in six of the last eight quarters, with growth averaging 9.5%.
- The fastest year-over-year change in Research & Development over five years came in Q4 2021 (growth of 96.8%), and the weakest in Q2 2026 (a decline of 20.2%).
- Business Quant data shows PMVP's Research & Development at $15.33 million (Q1 2026), $15.83 million (Q4 2025) and $18.21 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | PMV Pharmaceuticals | 72.71 Mn | -342.47 Mn | - | 14.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.68 Mn |
| Mar 31, 2026 | 15.33 Mn |
| Dec 31, 2025 | 15.83 Mn |
| Sep 30, 2025 | 18.21 Mn |
| Jun 30, 2025 | 18.40 Mn |
| Mar 31, 2025 | 17.44 Mn |
| Dec 31, 2024 | 13.77 Mn |
| Sep 30, 2024 | 16.95 Mn |
| Jun 30, 2024 | 14.63 Mn |
| Mar 31, 2024 | 13.19 Mn |
| Dec 31, 2023 | 13.38 Mn |
| Sep 30, 2023 | 13.59 Mn |
| Jun 30, 2023 | 13.84 Mn |
| Mar 31, 2023 | 15.07 Mn |
| Dec 31, 2022 | 15.03 Mn |
| Sep 30, 2022 | 13.67 Mn |
| Jun 30, 2022 | 11.46 Mn |
| Mar 31, 2022 | 11.84 Mn |
| Dec 31, 2021 | 12.17 Mn |
| Sep 30, 2021 | 9.16 Mn |
API Access
PMV Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PMVP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PMVP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PMVP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();